About us Dr. Reddy’s Laboratories Ltd. (BSE:
Post# of 7800
(Total Views: 254)
Posted On: 10/30/2023 12:14:14 PM
About us
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services
including APIs, generics, branded generics, biosimilars and <<<OTC>>>>.
Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, <<<<pain management>>>> and dermatology.
Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.
As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future.
As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance.
For more information, log on to: www.drreddys.com.
https://www.linkedin.com/company/dr--reddys-laboratories
Erin follows!
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services
including APIs, generics, branded generics, biosimilars and <<<OTC>>>>.
Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, <<<<pain management>>>> and dermatology.
Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.
As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future.
As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance.
For more information, log on to: www.drreddys.com.
https://www.linkedin.com/company/dr--reddys-laboratories
Erin follows!
(1)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼